DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,363,606 | -24.5% | 5,496 | -27.0% | 0.05% | -23.2% |
Q2 2023 | $1,806,744 | -7.2% | 7,528 | -2.6% | 0.07% | -13.8% |
Q1 2023 | $1,947,106 | -10.8% | 7,725 | -6.0% | 0.08% | -18.4% |
Q4 2022 | $2,181,815 | +9.5% | 8,220 | +6.5% | 0.10% | -4.9% |
Q3 2022 | $1,993,000 | +1.7% | 7,717 | -0.2% | 0.10% | -20.8% |
Q2 2022 | $1,960,000 | -15.2% | 7,733 | -1.9% | 0.13% | +0.8% |
Q1 2022 | $2,312,000 | +21.3% | 7,881 | +36.1% | 0.13% | +27.7% |
Q4 2021 | $1,906,000 | +8.9% | 5,792 | +0.7% | 0.10% | -2.9% |
Q3 2021 | $1,751,000 | +13.6% | 5,752 | +0.1% | 0.10% | +14.3% |
Q2 2021 | $1,542,000 | +23.7% | 5,746 | +3.7% | 0.09% | +7.1% |
Q1 2021 | $1,247,000 | -2.6% | 5,542 | -3.8% | 0.08% | -10.5% |
Q4 2020 | $1,280,000 | +34.0% | 5,761 | +29.9% | 0.10% | +14.5% |
Q3 2020 | $955,000 | +37.8% | 4,436 | +13.1% | 0.08% | +22.1% |
Q2 2020 | $693,000 | +26.5% | 3,921 | -1.0% | 0.07% | -8.1% |
Q1 2020 | $548,000 | -9.4% | 3,960 | +0.5% | 0.07% | +15.6% |
Q4 2019 | $605,000 | +64.0% | 3,939 | +54.1% | 0.06% | +30.6% |
Q3 2019 | $369,000 | +6.0% | 2,556 | +5.0% | 0.05% | +8.9% |
Q2 2019 | $348,000 | +7.7% | 2,435 | -0.4% | 0.04% | -6.2% |
Q1 2019 | $323,000 | +32.9% | 2,444 | +3.9% | 0.05% | 0.0% |
Q4 2018 | $243,000 | +4.3% | 2,352 | +9.5% | 0.05% | +37.1% |
Q3 2018 | $233,000 | – | 2,147 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |